Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SS Innovations International ( (SSII) ) has issued an update.
On October 28, 2025, SS Innovations International announced its third-quarter financial results, reporting a 192.5% increase in revenue to $12.8 million, driven by higher sales of the SSi Mantra 3 unit. Despite a net loss of $3.7 million, the company saw significant growth in installations and surgeries, with a 350% increase in SSi Mantra installations compared to the previous year. The company is progressing towards regulatory milestones, including a 510(k) submission to the FDA and a European Union CE marking certification, indicating robust growth prospects.
The most recent analyst rating on (SSII) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on SS Innovations International stock, see the SSII Stock Forecast page.
Spark’s Take on SSII Stock
According to Spark, TipRanks’ AI Analyst, SSII is a Neutral.
SS Innovations International’s overall stock score is primarily impacted by its financial performance challenges, including profitability and cash flow issues. While technical indicators show positive momentum, the valuation remains unattractive due to negative earnings and lack of dividends.
To see Spark’s full report on SSII stock, click here.
More about SS Innovations International
SS Innovations International, Inc. is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. The company focuses on the SSi Mantra surgical robotic system, which has gained regulatory approval in seven countries and is expanding its market presence in India and abroad.
Average Trading Volume: 85,202
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.74B
Find detailed analytics on SSII stock on TipRanks’ Stock Analysis page.